High Quality Human Biospecimens for Research and Development

With a growing global network of over 1500 clinical sites and biorepositories spanning North America, Europe, Australia, Africa, Asia, and South America, we specialize in sourcing high-quality biospecimens and clinical data. Our approach ensures that the highest ethical and clinical standards are met, enabling the procurement of both banked and prospectively collected human biospecimens across diverse patient populations and disease types.

Biospecimens

iProcess is your trusted partner for human biospecimens, with over 20 years of experience and an ever-growing global network of over 1500 clinical sites. We are able to provide many types of biospecimens including tissues, blood, plasma, serum, urine, stool, and swab samples.

Join the growing list of Pharmaceutical, Life Science and Diagnostic companies who are using iProcess Global Research to meet their research needs.

FAQs for Biospecimen Collection Services

A prospective biospecimen collection refers to the process of collecting human biological samples specifically for a defined research project or study. These collections are conducted after a request is made, meaning the samples are collected in the future based on customized criteria such as donor demographics, health conditions, collection method, and/or processing requirements.

Banked biospecimens are samples that have already been collected, processed, and stored, often as part of biobanks or previous research efforts. These specimens are ready for immediate use, typically with associated de-identified clinical and demographic data.

We provide a wide range of human biospecimens, including tissue, blood, plasma, serum, urine, saliva, tissue, and biofluids. We offer matched sets (e.g., tumor/normal tissue), disease-state samples, and healthy samples based on your request.

Our specimens are sourced from our global site network with access to individuals consented through IRB-approved protocols. Donors may be healthy volunteers or patients diagnosed with specific diseases, depending on the study requirements.

Yes. All collections are conducted under IRB/EC-approved protocols and follow all applicable regulations, including HIPAA and FDA guidelines, to ensure ethical sourcing, donor confidentiality, and proper handling.

Absolutely. We offer customized collection solutions tailored to specific research needs, including rare disease cohorts, longitudinal studies, and specialized sample processing.

Each specimen comes with de-identified demographic, clinical, and/or pathology data as permitted by the IRB and donor consent. Additional metadata can be included based on your protocol requirements.

Specimens are collected, processed, and stored following strict SOPs to preserve integrity and usability. We offer multiple preservation formats such as fresh, frozen, FFPE, or cryopreserved depending on your needs. For prospective collections, we can implement your custom processing and storage procedures to ensure that samples meet your specific needs.

Turnaround time varies depending on specimen type and collection complexity. Common biospecimens may be shipped within days, while custom collections may take several weeks or months. We work closely with clients to meet project timelines.

Yes, we ship biospecimens worldwide in accordance with IATA and local regulations. We ensure all shipments are packaged and handled to maintain sample quality during transit.

Yes, our team provides full support for protocol and informed consent development and IRB submission to align with your collection goals and regulatory requirements.